SCHEMBL6923966

SCHEMBL6923966

CC(C)c1cccc(C(C)C)c1N1C(=S)c2ccccc2C1=S

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 5/20 0.78
NR1H2 P55055 1/20 0.78
NR1H3 Q13133 1/20 0.78
ANPEP P15144 5/20 0.62
GABRA1 P14867 3/20 0.39
FAAH O00519 2/20 0.39
GABRB2 P47870 2/20 0.39
TSHR P16473 2/20 0.39
GABRG2 P18507 2/20 0.39
GABRB3 P28472 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
HPGD P15428 1/20 0.39
GABRB1 P18505 1/20 0.39
PTGS1 P23219 1/20 0.39
SLC6A2 P23975 1/20 0.39
HTR2C P28335 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6927281 0.88 DPP4 (1.00) DPP4NR1H2NR1H3ANPEPFAAH
SCHEMBL29366407 0.77 DPP4 (0.78) DPP4NR1H2NR1H3ANPEPFAAH
SCHEMBL2820118 0.77 DPP4 (0.78) DPP4NR1H2NR1H3ANPEPFAAH
SCHEMBL12055788 0.74 DPP4 (0.48) DPP4NR1H2NR1H3ANPEPCYP1A2
SCHEMBL9612014 0.73 DPP4 (0.63) DPP4NR1H2NR1H3ANPEPGABRA1
SCHEMBL28152643 0.69 DPP4 (0.46) DPP4NR1H2NR1H3ANPEPGABRA1
SCHEMBL167078 0.69 GABRA1 (0.55) DPP4NR1H2NR1H3GABRA1FAAH
SCHEMBL29414063 0.69 GABRA1 (0.55) DPP4NR1H2NR1H3GABRA1FAAH
SCHEMBL2032898 0.68 MGLL (0.63) DPP4NR1H2NR1H3ANPEPGABRA1
SCHEMBL300362 0.68 DPP4 (0.61) DPP4NR1H2NR1H3ANPEPHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6515129-B1 A pharmaceutical composition which comprises, a cyclic imide derivative represented by the general formula (I): present invention relates to an aminopeptidase N inhibitor or an angiogenesis inhibitor, modulates production of tumor necrosis ISHIHARA SANGYO KAISHA LTD. (JP) 2003-02-04 US disclosed
US-6429212-B1 AMINOPEPTIDASE N INHIBITOR USED TO TREAT CANCER, TUMORS, AND RETINOPATHY; FEW SIDE EFFECTS; ANGIOGENESIS INHIBITOR ISHIHARA SANGYO KAISHA LTD. (JP) 2002-08-06 US disclosed